China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 28.48
(-1.69%)
CNY 28.48
(-1.69%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.88 Billion CNY | -26.13% |
| 2022 | -1.49 Billion CNY | 3.35% |
| 2021 | -1.54 Billion CNY | -265.55% |
| 2020 | -423.5 Million CNY | -875.08% |
| 2019 | 54.63 Million CNY | 109.31% |
| 2018 | -586.89 Million CNY | -2478.81% |
| 2017 | 24.67 Million CNY | 106.17% |
| 2016 | -399.99 Million CNY | 38.77% |
| 2015 | -653.29 Million CNY | -88.85% |
| 2014 | -345.93 Million CNY | 13.2% |
| 2013 | -398.52 Million CNY | 23.47% |
| 2012 | -520.73 Million CNY | -1263.36% |
| 2011 | -38.19 Million CNY | -295.85% |
| 2010 | 19.5 Million CNY | 702.46% |
| 2009 | 2.43 Million CNY | -93.91% |
| 2008 | 39.89 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -1.84 Billion CNY | 41.7% |
| 2024 Q2 | -3.15 Billion CNY | -71.99% |
| 2024 Q1 | -1.83 Billion CNY | 2.72% |
| 2023 Q4 | -1.88 Billion CNY | -43.17% |
| 2023 FY | -1.88 Billion CNY | -26.13% |
| 2023 Q1 | -1.69 Billion CNY | -13.51% |
| 2023 Q2 | -1.9 Billion CNY | -12.31% |
| 2023 Q3 | -1.31 Billion CNY | 30.9% |
| 2022 FY | -1.49 Billion CNY | 3.35% |
| 2022 Q1 | -856.9 Million CNY | 44.65% |
| 2022 Q2 | -971.57 Million CNY | -13.38% |
| 2022 Q3 | -1.06 Billion CNY | -9.4% |
| 2022 Q4 | -1.49 Billion CNY | -40.77% |
| 2021 Q3 | -753.32 Million CNY | -91.41% |
| 2021 Q2 | -393.57 Million CNY | 27.22% |
| 2021 FY | -1.54 Billion CNY | -265.55% |
| 2021 Q1 | -540.77 Million CNY | -27.69% |
| 2021 Q4 | -1.54 Billion CNY | -105.5% |
| 2020 Q2 | 132.87 Million CNY | 21.81% |
| 2020 Q1 | 109.08 Million CNY | 99.65% |
| 2020 FY | -423.5 Million CNY | -875.08% |
| 2020 Q3 | -45.72 Million CNY | -134.41% |
| 2020 Q4 | -423.5 Million CNY | -826.27% |
| 2019 Q1 | -113.92 Million CNY | 80.59% |
| 2019 Q3 | -23.94 Million CNY | -184.22% |
| 2019 Q4 | 54.63 Million CNY | 328.23% |
| 2019 FY | 54.63 Million CNY | 109.31% |
| 2019 Q2 | 28.42 Million CNY | 124.95% |
| 2018 Q3 | 186.05 Million CNY | 276.52% |
| 2018 FY | -586.89 Million CNY | -2478.81% |
| 2018 Q2 | 49.41 Million CNY | -77.95% |
| 2018 Q1 | 224.15 Million CNY | 808.55% |
| 2018 Q4 | -586.89 Million CNY | -415.44% |
| 2017 Q4 | 24.67 Million CNY | 120.19% |
| 2017 Q3 | -122.2 Million CNY | 43.72% |
| 2017 Q1 | -356.01 Million CNY | 11.0% |
| 2017 Q2 | -217.12 Million CNY | 39.01% |
| 2017 FY | 24.67 Million CNY | 106.17% |
| 2016 Q4 | -399.99 Million CNY | 12.94% |
| 2016 Q2 | -493.6 Million CNY | 16.59% |
| 2016 FY | -399.99 Million CNY | 38.77% |
| 2016 Q1 | -591.75 Million CNY | 9.42% |
| 2016 Q3 | -459.43 Million CNY | 6.92% |
| 2015 Q2 | -215.01 Million CNY | 37.45% |
| 2015 Q1 | -343.74 Million CNY | 0.63% |
| 2015 Q4 | -653.29 Million CNY | -203.6% |
| 2015 FY | -653.29 Million CNY | -88.85% |
| 2015 Q3 | -215.17 Million CNY | -0.08% |
| 2014 FY | -345.93 Million CNY | 13.2% |
| 2014 Q2 | -312.46 Million CNY | 6.1% |
| 2014 Q4 | -345.93 Million CNY | -7.5% |
| 2014 Q3 | -321.8 Million CNY | -2.99% |
| 2014 Q1 | -332.77 Million CNY | 16.5% |
| 2013 Q2 | -502.9 Million CNY | -1.11% |
| 2013 FY | -398.52 Million CNY | 23.47% |
| 2013 Q4 | -398.52 Million CNY | 23.98% |
| 2013 Q3 | -524.26 Million CNY | -4.25% |
| 2013 Q1 | -497.37 Million CNY | 4.49% |
| 2012 FY | -520.73 Million CNY | -1263.36% |
| 2012 Q2 | -475.41 Million CNY | 0.79% |
| 2012 Q1 | -479.18 Million CNY | -1154.59% |
| 2012 Q4 | -520.73 Million CNY | -3.64% |
| 2012 Q3 | -502.42 Million CNY | -5.68% |
| 2011 FY | -38.19 Million CNY | -295.85% |
| 2011 Q4 | -38.19 Million CNY | 0.0% |
| 2010 FY | 19.5 Million CNY | 702.46% |
| 2009 FY | 2.43 Million CNY | -93.91% |
| 2008 FY | 39.89 Million CNY | 0.0% |